The employer of the European generic, biosimilar and value-added medicines industry, Medicines for Europe, has just announced the appointment of Marc Alexander Mahl as the new president of the organization for the next two years.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
